An IT Approach to Implementing Depression Treatment in Cardiac Patients (iHeart DepCare)

Description

The purpose of this study is to examine the effect of a brief electronic shared decision making (eSDM) intervention on depressive symptoms in coronary heart disease patients with elevated depressive symptoms.

Conditions

Depressive Symptoms, Coronary Heart Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to examine the effect of a brief electronic shared decision making (eSDM) intervention on depressive symptoms in coronary heart disease patients with elevated depressive symptoms.

An Information TecHnology Approach to ImplEmenting Depression TreAtment in CaRdiac PatienTs: [iHeartDepCare Trial]

An IT Approach to Implementing Depression Treatment in Cardiac Patients (iHeart DepCare)

Condition
Depressive Symptoms
Intervention / Treatment

-

Contacts and Locations

New York

Columbia University Irving Medical Center/New York Presbyterian Hospital, New York, New York, United States, 10032

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * History of coronary heart disease
  • * English or Spanish Speaking
  • * Elevated Depressive symptoms (PHQ9 ≥10)
  • * Appointment at participating cardiology or primary care clinics
  • * Under the care of a psychiatrist \[\*\*On 6/22/2022, this exclusion criteria was removed for those clusters of clinics not already in the post-implementation period\*\*\]
  • * Diagnosis/history of psychosis or schizophrenia
  • * Diagnosis/history of bipolar disorder
  • * Attempted suicide
  • * Non-English or Spanish speaking
  • * Dementia or severe cognitive impairment
  • * Non-elevated depressive symptoms
  • * Alcohol or substance abuse
  • * Pregnancy

Ages Eligible for Study

21 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Columbia University,

Nathalie Moise, MD, MS, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

2025-12-01